561 related articles for article (PubMed ID: 26844759)
1. The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders.
Smith DK; He M; Zhang CL; Zheng JC
Prog Neurobiol; 2017 Oct; 157():212-229. PubMed ID: 26844759
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases.
Li R; Bai Y; Liu T; Wang X; Wu Q
Protein Cell; 2013 Jun; 4(6):415-24. PubMed ID: 23686735
[TBL] [Abstract][Full Text] [Related]
3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
4. Somatic cell reprogramming as a tool for neurodegenerative diseases.
Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of somatic cells to induced neural stem cells.
Shahbazi E; Mirakhori F; Ezzatizadeh V; Baharvand H
Methods; 2018 Jan; 133():21-28. PubMed ID: 28939501
[TBL] [Abstract][Full Text] [Related]
6. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
8. Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming.
Legault EM; Bouquety J; Drouin-Ouellet J
Cell Reprogram; 2022 Oct; 24(5):228-251. PubMed ID: 35749150
[TBL] [Abstract][Full Text] [Related]
9. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
Ito D; Yagi T; Suzuki N
Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
[TBL] [Abstract][Full Text] [Related]
10. Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain.
López-León M; Outeiro TF; Goya RG
Ageing Res Rev; 2017 Nov; 40():168-181. PubMed ID: 28903069
[TBL] [Abstract][Full Text] [Related]
11. Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming.
Chen Y; Pu J; Zhang B
Hum Gene Ther; 2016 Dec; 27(12):962-970. PubMed ID: 27589383
[TBL] [Abstract][Full Text] [Related]
12. Introduction for Stem Cell-Based Therapy for Neurodegenerative Diseases.
Han F; Lu P
Adv Exp Med Biol; 2020; 1266():1-8. PubMed ID: 33105491
[TBL] [Abstract][Full Text] [Related]
13. Advances in reprogramming-based study of neurologic disorders.
Nityanandam A; Baldwin KK
Stem Cells Dev; 2015 Jun; 24(11):1265-83. PubMed ID: 25749371
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Neural Stem Cells and Progenitors: Neuronal Production and Grafting Applications.
Zholudeva LV; Jin Y; Qiang L; Lane MA; Fischer I
Methods Mol Biol; 2021; 2311():73-108. PubMed ID: 34033079
[TBL] [Abstract][Full Text] [Related]
15. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.
Qiang L; Fujita R; Abeliovich A
Neuron; 2013 Jun; 78(6):957-69. PubMed ID: 23791192
[TBL] [Abstract][Full Text] [Related]
16. Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells.
Biswas D; Jiang P
Int J Mol Sci; 2016 Feb; 17(2):226. PubMed ID: 26861316
[TBL] [Abstract][Full Text] [Related]
17. Human-induced pluripotent stem cells: potential for neurodegenerative diseases.
Ross CA; Akimov SS
Hum Mol Genet; 2014 Sep; 23(R1):R17-26. PubMed ID: 24824217
[TBL] [Abstract][Full Text] [Related]
18. Neural stem cell-based treatment for neurodegenerative diseases.
Kim SU; Lee HJ; Kim YB
Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
[TBL] [Abstract][Full Text] [Related]
19. Induced Pluripotency: A Powerful Tool for In Vitro Modeling.
Zahumenska R; Nosal V; Smolar M; Okajcekova T; Skovierova H; Strnadel J; Halasova E
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255453
[TBL] [Abstract][Full Text] [Related]
20. Progress in the reprogramming of somatic cells.
Ma T; Xie M; Laurent T; Ding S
Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
